Cystadenocarcinoma, Papillary
"Cystadenocarcinoma, Papillary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.
| Descriptor ID |
D018283
|
| MeSH Number(s) |
C04.557.470.200.025.480.230 C04.557.470.590.480.230
|
| Concept/Terms |
Cystadenocarcinoma, Papillary- Cystadenocarcinoma, Papillary
- Cystadenocarcinomas, Papillary
- Papillary Cystadenocarcinoma
- Papillary Cystadenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Cystadenocarcinoma, Papillary".
Below are MeSH descriptors whose meaning is more specific than "Cystadenocarcinoma, Papillary".
This graph shows the total number of publications written about "Cystadenocarcinoma, Papillary" by people in this website by year, and whether "Cystadenocarcinoma, Papillary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 5 | 1 | 6 |
| 2000 | 4 | 2 | 6 |
| 2001 | 4 | 1 | 5 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cystadenocarcinoma, Papillary" by people in Profiles.
-
Low-grade serous ovarian cancer: expert consensus report on the state of the science. Int J Gynecol Cancer. 2023 09 04; 33(9):1331-1344.
-
The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes. Gynecol Oncol. 2022 06; 165(3):560-567.
-
Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers. Gynecol Oncol. 2020 01; 156(1):77-84.
-
Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp. Int J Gynecol Pathol. 2016 May; 35(3):249-55.
-
Solitary brain metastasis in a patient with ovarian cancer with BRCA2 mutation. J Clin Oncol. 2012 Sep 01; 30(25):e239-40.
-
Syringocystadenocarcinoma papilliferum with transition to areas of squamous differentiation: a case report and review of the literature. Am J Dermatopathol. 2012 Jun; 34(4):428-33.
-
HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. Cancer Res. 2011 Jan 15; 71(2):349-59.
-
Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature. Arch Pathol Lab Med. 2010 Aug; 134(8):1205-9.
-
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol. 2006 Aug; 108(2):361-8.
-
Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005 Jul; 98(1):77-83.